GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
A tanker ship that arrived in Russia from Belgium was rigged with NATO-made mines, the Investigative Committee has said...
Democratic Senate candidate Graham Platner faces backlash from veterans and senators over deleted posts calling soldiers "trash" and mocking a wounded Purple Heart recipient....
Rep. Ilhan Omar says she is unbothered by Rep. Nancy Mace's proposed constitutional amendment that would bar foreign-born individuals from serving in Congress....
